This is the text extract for Proposal to fund healthE Fatty Cream (oil in water emulsion). Closed, browse documents here.

26 June 2009

Proposal to fund healthE Fatty Cream (oil in water emulsion)

PHARMAC is seeking feedback on a proposal to fund a new brand of oil in water emulsion cream (healthE Fatty Cream) on the Pharmaceutical Schedule. This proposal would result in: • healthE Fatty Cream being listed in Section B and Section H of the Pharmaceutical from 1 October 2009 at the following price and subsidy (ex-manufacturer and exclusive of GST):

Chemical Oil in water emulsion Presentation Cream Brand healthE Fatty Cream Pack size 500 g Price and subsidy $2.80

•

healthE Fatty Cream would have subsidy and delisting protection until 30 September 2012.

Feedback sought PHARMAC welcomes feedback on this proposal. To provide feedback, please submit it in writing by Friday 10 July 2009 to: Mike Bignall Therapeutic Group Manager PHARMAC Email: mike.bignall@pharmac.govt.nz Fax: 04 460 4995 Post: PO Box 10 254, Wellington 6143

All feedback received before the closing date will be considered by PHARMAC’s Board (or Chief Executive acting under delegated authority) prior to making a decision on this proposal.

Background PHARMAC and Jaychem Industries Limited have entered into a provisional agreement relating to the supply of oil in water emulsion cream (healthE Fatty Cream), which is made to the same formulation as the currently funded Lemnis Fatty Cream. We note that stocks of Lemnis Fatty Cream, as supplied by CSL Biotherapies, are almost depleted and that that the supplier has notified that this brand will be discontinued at that time. As a result Lemnis Fatty Cream will be delisted from the Pharmaceutical Schedule later this year. This proposal would ensure that a suitable alternative brand was funded to ensure continuity of supply.

A283870

Page 1 of 1